* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
5591 | PRKDC | C4014833 | IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES | 0.4 | ORPHANET;UNIPROT |
5591 | PRKDC | C0085110 | Severe Combined Immunodeficiency | 0.202472541057918 | BEFREE;HPO |
5591 | PRKDC | C4277682 | Chemical and Drug Induced Liver Injury | 0.2 | CTD_human |
5591 | PRKDC | C0001364 | Massive Hepatic Necrosis | 0.2 | CTD_human |
5591 | PRKDC | C4020899 | Autosomal recessive predisposition | 0.2 | HPO |
5591 | PRKDC | C3163798 | Recurrent lower respiratory tract infection | 0.2 | HPO |
5591 | PRKDC | C2937365 | Recurrent aphthous ulcer | 0.2 | HPO |
5591 | PRKDC | C1848924 | Infantile onset | 0.2 | HPO |
5591 | PRKDC | C0424688 | Small head | 0.2 | HPO |
5591 | PRKDC | C0149725 | Lower respiratory tract infection | 0.2 | HPO |
5591 | PRKDC | C0038363 | Aphthous Stomatitis | 0.2 | HPO |
5591 | PRKDC | C0033578 | Prostatic Neoplasms | 0.2 | CTD_human |
5591 | PRKDC | C0024115 | Lung diseases | 0.2 | CTD_human |
5591 | PRKDC | C0019151 | Hepatic Encephalopathy | 0.2 | CTD_human |
5591 | PRKDC | C0010606 | Adenoid Cystic Carcinoma | 0.2 | CTD_human |
5591 | PRKDC | C0007137 | Squamous cell carcinoma | 0.2 | CTD_human |
5591 | PRKDC | C1832322 | Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive | 0.08 | MGD |
5591 | PRKDC | C0006142 | Malignant neoplasm of breast | 0.0110017480142175 | BEFREE;GAD |
5591 | PRKDC | C1458155 | Mammary Neoplasms | 0.00819873739444126 | LHGDN |
5591 | PRKDC | C0005684 | Malignant neoplasm of urinary bladder | 0.0074958123540771 | BEFREE;GAD |
5591 | PRKDC | C0004135 | Ataxia Telangiectasia | 0.0062900052822668 | BEFREE;LHGDN |
5591 | PRKDC | C0376358 | Malignant neoplasm of prostate | 0.0059129641834284 | BEFREE;GAD |
5591 | PRKDC | C0153633 | Malignant neoplasm of brain | 0.004814057046576 | GAD |
5591 | PRKDC | C0017636 | Glioblastoma | 0.00410654638587925 | BEFREE;LHGDN |
5591 | PRKDC | C0017638 | Glioma | 0.0037806624443535 | BEFREE;GAD |
5591 | PRKDC | C0027627 | Neoplasm Metastasis | 0.00328236603323995 | BEFREE;LHGDN |
5591 | PRKDC | C0005695 | Bladder Neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
5591 | PRKDC | C0004114 | Astrocytoma | 0.00273291246481375 | LHGDN |
5591 | PRKDC | C0023418 | leukemia | 0.00273291246481375 | LHGDN |
5591 | PRKDC | C0038356 | Stomach Neoplasms | 0.00273291246481375 | LHGDN |
5591 | PRKDC | C3714514 | Infection | 0.00273291246481375 | LHGDN |
5591 | PRKDC | C0024121 | Lung Neoplasms | 0.00273291246481375 | LHGDN |
5591 | PRKDC | C0006118 | Brain Neoplasms | 0.0026817553075011 | BEFREE;GAD |
5591 | PRKDC | C0278996 | Cancer of Head and Neck | 0.002407028523288 | GAD |
5591 | PRKDC | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
5591 | PRKDC | C0026769 | Multiple Sclerosis | 0.002407028523288 | GAD |
5591 | PRKDC | C0040136 | Thyroid Neoplasm | 0.002407028523288 | GAD |
5591 | PRKDC | C0242379 | Malignant neoplasm of lung | 0.002407028523288 | GAD |
5591 | PRKDC | C0024305 | Lymphoma, Non-Hodgkin | 0.002407028523288 | GAD |
5591 | PRKDC | C0023434 | Chronic Lymphocytic Leukemia | 0.002407028523288 | GAD |
5591 | PRKDC | C0007133 | Carcinoma, Papillary | 0.002407028523288 | GAD |
5591 | PRKDC | C2239176 | Liver carcinoma | 0.0010989071368524 | BEFREE |
5591 | PRKDC | C0678222 | Breast Carcinoma | 0.0010989071368524 | BEFREE |
5591 | PRKDC | C0600139 | Prostate carcinoma | 0.0010989071368524 | BEFREE |
5591 | PRKDC | C0007131 | Non-Small Cell Lung Carcinoma | 0.0008241803526393 | BEFREE |
5591 | PRKDC | C0178874 | Tumor Progression | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C0699790 | Colon Carcinoma | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C1512409 | Hepatocarcinogenesis | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C1168401 | Squamous cell carcinoma of the head and neck | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C0596263 | Carcinogenesis | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C1527249 | Colorectal Cancer | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C0009402 | Colorectal Carcinoma | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C0025202 | melanoma | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C0004364 | Autoimmune Diseases | 0.0005494535684262 | BEFREE |
5591 | PRKDC | C1865370 | Severe combined immunodeficiency with sensitivity to ionizing radiation | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0558355 | Tonsillar Carcinoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0585442 | Osteosarcoma of bone | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C4048328 | cervical cancer | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C3828416 | Radiation Damage | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0004134 | Ataxia | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C1261473 | Sarcoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0699791 | Stomach Carcinoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0699885 | Carcinoma of bladder | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0700095 | Central neuroblastoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C1621958 | Glioblastoma Multiforme | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0948750 | Salivary gland carcinoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0002726 | Amyloidosis | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0029463 | Osteosarcoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0007758 | Cerebellar Ataxia | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0007847 | Malignant tumor of cervix | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0015625 | Fanconi Anemia | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0021051 | Immunologic Deficiency Syndromes | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0023473 | Myeloid Leukemia, Chronic | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0023531 | Leukoplakia | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0024141 | Lupus Erythematosus, Systemic | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0024299 | Lymphoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0024623 | Malignant neoplasm of stomach | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0025149 | Medulloblastoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0026764 | Multiple Myeloma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0027819 | Neuroblastoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0555198 | Malignant Glioma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0043346 | Xeroderma Pigmentosum | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0005699 | Blast Phase | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0085281 | Addictive Behavior | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0149925 | Small cell carcinoma of lung | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0153690 | Secondary malignant neoplasm of bone | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0206656 | Rhabdomyosarcoma, Embryonal | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0270814 | Spastic syndrome | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0275524 | Coinfection | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0302592 | Cervix carcinoma | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0338656 | Impaired cognition | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0346429 | Multiple malignancy | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0398686 | Primary immune deficiency disorder | 0.0002747267842131 | BEFREE |
5591 | PRKDC | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |